The ATOMIX multicentre, controlled clinical trial compared the efficacy and safety of atorvastatin and bezafibrate in patients with diet-resistant combined hyperlipidaemia. Patients and study ...

In this multicentre, randomised clinical trial of 1-year duration, 138 patients with CHL under close dietary supervision received atorvastatin or bezafibrate as lipid-regulating agents.